About
Ms. Johnson is the President, Co-Founder and Chief Executive Officer of TRACT Therapeutics, Inc., a clinical stage biotechnology company focused on novel cellular therapy to regulate a patient’s immune system. She is a veteran biotechnology industry executive with more than 30 years of experience in the start-up and successful commercialization of innovative cell-based products for several therapeutic indications. Prior to founding TRACT Therapeutics, Ms. Johnson successfully commercialized several early stage technologies while serving in Executive Management positions at BioSurface Technology, Genzyme Corporation and KeraCure, Inc. At BioSurface Technology (acquired by Genzyme), Ms. Johnson commercialized the first cellular therapy ever which resulted in early adoption of novel autologous cell therapies and paved the way for future innovative cellular therapies to treat a variety of indications. Prior to TRACT Therapeutics, Ms. Johnson founded and grew all aspects of KeraCure, Inc.,
Position in the VCSift Database
- • 14 investors hold the Co-Founder, President & CEO role in VCSift. Gretchen S Johnson is one of them.
- • 1,718 investors are based in Chicago, Illinois, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Chicago, US
Contact Information
Find more investors like Gretchen
Search Investors